Indeed your proposed question is well thought out and simplistically stated for all to understand... my only tweeks would be as follows below in bold because the company and drug name are already out in the public domain (via previous interviews, correspondence with FDA, etc.):

Quote:

---

“ mr. President, is it true that there is an American company, CytoDyn that is allowing critically ill patients to recover, get out of the ICU and off of ventilators with no side effects from its drug, Leronlimab - and is also showing promise in keeping mild and moderate patients from progressing”?

---